KT&G to Enhance Competition in Eurasia with Uzbekistan Expansion.

Jan.14.2025
KT&G to Enhance Competition in Eurasia with Uzbekistan Expansion.
KT&G to establish legal entity in Uzbekistan to enhance competitiveness in Eurasian market, following successful localization efforts.

According to a report by N. News on January 13th, Korean Tobacco (referred to as "KT&G" hereafter) announced plans to establish a corporate entity in Uzbekistan, aiming to enhance their competitive edge in the Eurasian region.


Previously, KT&G had established an office in Uzbekistan in 2023 and exported localized products of the ultra-slim cigarette brand "ESSE". In 2024, sales of seven "ESSE" products in Uzbekistan totaled 270 million units, with the best-selling product "Esse Change" accounting for 64% of the exports.


By transforming its office in Uzbekistan into a legal entity, KT&G plans to enhance its long-term competitiveness in the Eurasian region. The company also plans to increase its local workforce by more than fourfold and establish a more comprehensive sales network to strengthen its market position.


On the other hand, KT&G established regional CICs (Corporate Independent Companies) in the Eurasia and Asia-Pacific regions last year. Currently, KT&G operates in 132 countries worldwide with 6 sales corporations and 3 offices. KT&G stated that it will continue to strengthen its direct business system to enhance profitability.


A representative from KT&G stated that establishing a legal entity in Uzbekistan is part of their continued goal to become a "global top-tier" company, following the establishment of a legal entity in Kazakhstan in 2023. This move is also part of their investment and innovation strategy. KT&G plans to drive global business growth by strengthening their local business systems in the future.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
A study using 2020–2023 U.S. data from the ITC Youth Tobacco and Vaping Survey (ages 16–19) reports that both nicotine/tobacco use and internalizing mental health (IMH) symptoms vary across disaggregated gender identities, and that gender identity moderates the relationship between IMH symptoms and product use.
Feb.27 by 2FIRSTS.ai
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
Scientific talk in Bursa Nilüfer spotlights cigarette and e-cigarette addiction and youth risks
Scientific talk in Bursa Nilüfer spotlights cigarette and e-cigarette addiction and youth risks
Nilüfer Municipality in Bursa held a scientific talk titled “Does Addiction Change Form? Cigarettes, E-Cigarettes and Lung Health” as part of February 9 Quit Smoking Day, aiming to raise awareness of the social impact of tobacco addiction. Experts discussed cigarette and e-cigarette addiction, risks for young people, harms of secondhand smoke for children, and health outcomes linked to tobacco use.
Feb.10 by 2FIRSTS.ai
Bulgarian Police Seize More Than 56,500 Heated Tobacco Sticks in Sofia Operation
Bulgarian Police Seize More Than 56,500 Heated Tobacco Sticks in Sofia Operation
Bulgaria’s Interior Ministry said two men aged 48 and 50 were detained during a specialised police operation in Sofia’s Krasna Polyana district for distributing e-cigarettes and tobacco without excise stamps.
Mar.17 by 2FIRSTS.ai
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s Federal Public Prosecutor’s Office (MPF) and health regulator Anvisa signed a cooperation protocol to strengthen enforcement against electronic smoking devices (DEFs) and expand health-risk awareness campaigns.
Feb.03 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24